115 related articles for article (PubMed ID: 21697784)
21. Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma.
Lang-Lazdunski L; Bille A; Lal R; Cane P; McLean E; Landau D; Steele J; Spicer J
J Thorac Oncol; 2012 Apr; 7(4):737-43. PubMed ID: 22425923
[TBL] [Abstract][Full Text] [Related]
22. Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decortication.
Wolf AS; Daniel J; Sugarbaker DJ
Semin Thorac Cardiovasc Surg; 2009; 21(2):132-48. PubMed ID: 19822285
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for major complications after extrapleural pneumonectomy for malignant pleural mesothelioma.
de Perrot M; McRae K; Anraku M; Karkouti K; Waddell TK; Pierre AF; Darling G; Keshavjee S; Johnston MR
Ann Thorac Surg; 2008 Apr; 85(4):1206-10. PubMed ID: 18355497
[TBL] [Abstract][Full Text] [Related]
24. The role of video assisted thoracoscopic pleurectomy/decortication in the therapeutic management of malignant pleural mesothelioma.
Nakas A; Martin Ucar AE; Edwards JG; Waller DA
Eur J Cardiothorac Surg; 2008 Jan; 33(1):83-8. PubMed ID: 18053737
[TBL] [Abstract][Full Text] [Related]
25. Is pleurectomy and decortication superior to palliative care in the treatment of malignant pleural mesothelioma?
Zahid I; Sharif S; Routledge T; Scarci M
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):812-7. PubMed ID: 21345818
[TBL] [Abstract][Full Text] [Related]
26. Low calretinin expression and high neutrophil-to-lymphocyte ratio are poor prognostic factors in patients with malignant mesothelioma undergoing extrapleural pneumonectomy.
Kao SC; Klebe S; Henderson DW; Reid G; Chatfield M; Armstrong NJ; Yan TD; Vardy J; Clarke S; van Zandwijk N; McCaughan B
J Thorac Oncol; 2011 Nov; 6(11):1923-9. PubMed ID: 22011651
[TBL] [Abstract][Full Text] [Related]
27. [Extrapleural pneumonectomy for malignant pleural mesothelioma].
Morohoshi T; Yamamoto T; Nagashima T
Kyobu Geka; 2007 Jan; 60(1):40-4. PubMed ID: 17249537
[TBL] [Abstract][Full Text] [Related]
28. The effects of an intentional transition from extrapleural pneumonectomy to extended pleurectomy/decortication.
Sharkey AJ; Tenconi S; Nakas A; Waller DA
Eur J Cardiothorac Surg; 2016 Jun; 49(6):1632-41. PubMed ID: 26637211
[TBL] [Abstract][Full Text] [Related]
29. Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma.
Neragi-Miandoab S; Richards WG; Sugarbaker DJ
Int J Surg; 2008 Aug; 6(4):293-7. PubMed ID: 18585112
[TBL] [Abstract][Full Text] [Related]
30. [Survey of surgical treatment of malignant pleural mesothelioma in Japan].
Higashiyama M; Morinaga K
Kyobu Geka; 2007 Jan; 60(1):19-24. PubMed ID: 17249533
[TBL] [Abstract][Full Text] [Related]
31. Is malignant pleural mesothelioma a surgical disease? A review of 83 consecutive extra-pleural pneumonectomies.
Trousse DS; Avaro JP; D'Journo XB; Doddoli C; Astoul P; Giudicelli R; Fuentes PA; Thomas PA
Eur J Cardiothorac Surg; 2009 Oct; 36(4):759-63. PubMed ID: 19523843
[TBL] [Abstract][Full Text] [Related]
32. Updated meta-analysis of survival after extrapleural pneumonectomy versus pleurectomy/decortication in mesothelioma.
Magouliotis DE; Tasiopoulou VS; Athanassiadi K
Gen Thorac Cardiovasc Surg; 2019 Mar; 67(3):312-320. PubMed ID: 30374811
[TBL] [Abstract][Full Text] [Related]
33. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically.
Rusch VW; Venkatraman ES
Ann Thorac Surg; 1999 Nov; 68(5):1799-804. PubMed ID: 10585061
[TBL] [Abstract][Full Text] [Related]
34. Malignant pleural mesothelioma: surgical management in 285 patients.
Schipper PH; Nichols FC; Thomse KM; Deschamps C; Cassivi SD; Allen MS; Pairolero PC
Ann Thorac Surg; 2008 Jan; 85(1):257-64; discussion 264. PubMed ID: 18154820
[TBL] [Abstract][Full Text] [Related]
35. Radical surgery for malignant pleural mesothelioma: results and prognosis.
Okada M; Mimura T; Ohbayashi C; Sakuma T; Soejima T; Tsubota N
Interact Cardiovasc Thorac Surg; 2008 Feb; 7(1):102-6. PubMed ID: 18048410
[TBL] [Abstract][Full Text] [Related]
36. Facility volume and postoperative outcomes for malignant pleural mesothelioma: A National Cancer Data Base analysis.
Verma V; Ahern CA; Berlind CG; Lindsay WD; Grover S; Culligan MJ; Friedberg JS; Simone CB
Lung Cancer; 2018 Jun; 120():7-13. PubMed ID: 29748018
[TBL] [Abstract][Full Text] [Related]
37. Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis.
Baud M; Strano S; Dechartres A; Jouni R; Triponez F; Chouaid C; Forgez P; Damotte D; Roche N; Régnard JF; Alifano M
J Thorac Cardiovasc Surg; 2013 May; 145(5):1305-11. PubMed ID: 23072703
[TBL] [Abstract][Full Text] [Related]
38. Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection.
Sugarbaker DJ; Gill RR; Yeap BY; Wolf AS; DaSilva MC; Baldini EH; Bueno R; Richards WG
J Thorac Cardiovasc Surg; 2013 Apr; 145(4):955-963. PubMed ID: 23434448
[TBL] [Abstract][Full Text] [Related]
39. Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy.
Patel PR; Yoo S; Broadwater G; Marks LB; Miles EF; D'Amico TA; Harpole D; Kelsey CR
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):362-8. PubMed ID: 22516382
[TBL] [Abstract][Full Text] [Related]
40. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy.
Sugarbaker DJ; Wolf AS; Chirieac LR; Godleski JJ; Tilleman TR; Jaklitsch MT; Bueno R; Richards WG
Eur J Cardiothorac Surg; 2011 Aug; 40(2):298-303. PubMed ID: 21310625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
